AAPLLoadingMSFTLoadingNVDALoadingGOOGLLoadingAMZNLoadingMETALoadingTSLALoadingAMDLoadingNFLXLoadingCOINLoadingPYPLLoadingSPYLoadingQQQLoadingIWMLoadingJPMLoadingVLoadingDISLoadingKOLoadingJNJLoadingNKELoadingXOMLoadingASMLLoading
FreeMSTR4 min read

A holding company with leverage is not the same as the asset

It traded at 154.55 this morning, -1.99% on the session. When a listed company's main activity is holding an asset you could buy yourself, the analysis is about the wrapper.

MSTR
Delayed

What the wrapper adds

Two things, and they point in opposite directions.

It adds leverage. Debt and equity issuance used to acquire more of the asset than the company's own cash would allow. In a rising market that magnifies the return. In a falling one it magnifies the other thing.

It adds a premium or discount. The shares trade at whatever the market decides, which is frequently not the value of the holdings. That gap moves on sentiment, index inclusion, and the perceived skill of the strategy, none of which are the asset.

The circularity worth noticing

If the shares trade above the value of the holdings, the company can issue equity, buy more of the asset, and increase the holdings per share. Which is genuinely accretive, and depends entirely on the premium persisting.

  • Premium or discount to the value of the holdings
  • Debt maturities and the terms, particularly any conversion features
  • Issuance history and whether it has been accretive at the prices used
  • What happens to all of the above if the premium becomes a discount

That last question is the one to sit with. The mechanism that creates value on the way up works in reverse, and it stops working before the asset does.

Why I am flat

If I want the asset I can own the asset. Owning it through a balance sheet means also underwriting the balance sheet.

When this would be interesting

At a discount to the holdings, with manageable maturities. That would be a genuinely different proposition: the asset acquired below its market value, with the leverage as the risk being paid for rather than the thing being paid up for.

The author holds no position in the instruments discussed. Opinion. Not advice. Not a financial promotion approved under FSMA s.21. Quote data is delayed. Past performance is not a reliable indicator of future results.

Comments

0 comments
Sign in to comment.

No comments yet

Be the first to weigh in.